Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Cost-effectiveness of newborn screening for severe combined immunodeficiency.

Van der Ploeg CPB, Blom M, Bredius RGM, van der Burg M, Schielen PCJI, Verkerk PH, Van den Akker-van Marle ME.

Eur J Pediatr. 2019 May;178(5):721-729. doi: 10.1007/s00431-019-03346-3. Epub 2019 Feb 25.

PMID:
30805731
2.

Cost-utility of a guided Internet-based intervention in comparison with attention only for people with HIV and depressive symptoms: A randomized controlled trial.

van Luenen S, Kraaij V, Garnefski N, Spinhoven P, van den Akker-van Marle ME.

J Psychosom Res. 2019 Mar;118:34-40. doi: 10.1016/j.jpsychores.2019.01.012. Epub 2019 Jan 18.

PMID:
30782352
3.

Cost-effectiveness analysis of pulse oximetry screening for critical congenital heart defects following homebirth and early discharge.

Narayen IC, Te Pas AB, Blom NA, van den Akker-van Marle ME.

Eur J Pediatr. 2019 Jan;178(1):97-103. doi: 10.1007/s00431-018-3268-x. Epub 2018 Oct 17.

4.

Quality of life and fear of cancer recurrence in T1 colorectal cancer patients treated with endoscopic or surgical tumor resection.

Dang H, de Vos Tot Nederveen Cappel WH, van der Zwaan SMS, van den Akker-van Marle ME, van Westreenen HL, Backes Y, Moons LMG, Holman FA, Peeters KCMJ, van der Kraan J, Langers AMJ, Lijfering WM, Hardwick JCH, Boonstra JJ.

Gastrointest Endosc. 2019 Mar;89(3):533-544. doi: 10.1016/j.gie.2018.09.026. Epub 2018 Sep 28.

PMID:
30273589
5.

[Medical scribe in a trauma surgery outpatient clinic; shorter, cheaper consultations and satisfied doctors].

Hasan S, Krijnen P, van den Akker-van Marle ME, Schipper IB, Bartlema KA.

Ned Tijdschr Geneeskd. 2018 Aug 30;162. pii: D2614. Dutch.

PMID:
30212013
6.

Healthcare costs attributable to congenital cytomegalovirus infection.

Korndewal MJ, Weltevrede M, van den Akker-van Marle ME, Oudesluys-Murphy AM, de Melker HE, Vossen ACTM.

Arch Dis Child. 2018 May;103(5):452-457. doi: 10.1136/archdischild-2017-312805. Epub 2018 Jan 23.

PMID:
29363491
7.

Differences in optimality index between planned place of birth in a birth centre and alternative planned places of birth, a nationwide prospective cohort study in The Netherlands: results of the Dutch Birth Centre Study.

Hermus MAA, Hitzert M, Boesveld IC, van den Akker-van Marle ME, Dommelen PV, Franx A, Graaf JP, Lith JMMV, Luurssen-Masurel N, Steegers EAP, Wiegers TA, Bruin KMVP.

BMJ Open. 2017 Nov 16;7(11):e016958. doi: 10.1136/bmjopen-2017-016958.

8.

Hospital variation in allogeneic transfusion and extended length of stay in primary elective hip and knee arthroplasty: a cross-sectional study.

Voorn VMA, Marang-van de Mheen PJ, van der Hout A, So-Osman C, van den Akker-van Marle ME, Koopman-van Gemert AWMM, Dahan A, Vliet Vlieland TPM, Nelissen RGHH, van Bodegom-Vos L; LISBOA study group.

BMJ Open. 2017 Jul 20;7(7):e014143. doi: 10.1136/bmjopen-2016-014143.

9.

Percutaneous laser disc decompression versus microdiscectomy for sciatica: Cost utility analysis alongside a randomized controlled trial.

van den Akker-van Marle ME, Brouwer PA, Brand R, Koes B, van den Hout WB, van Buchem MA, Peul WC.

Interv Neuroradiol. 2017 Oct;23(5):538-545. doi: 10.1177/1591019917710297. Epub 2017 Jul 5.

10.

Typology of birth centres in the Netherlands using the Rainbow model of integrated care: results of the Dutch Birth Centre Study.

Boesveld IC, Bruijnzeels MA, Hitzert M, Hermus MAA, van der Pal-de Bruin KM, van den Akker-van Marle ME, Steegers EAP, Franx A, de Vries RG, Wiegers TA.

BMC Health Serv Res. 2017 Jun 21;17(1):426. doi: 10.1186/s12913-017-2350-9.

11.

The effectiveness of a de-implementation strategy to reduce low-value blood management techniques in primary hip and knee arthroplasty: a pragmatic cluster-randomized controlled trial.

Voorn VMA, Marang-van de Mheen PJ, van der Hout A, Hofstede SN, So-Osman C, van den Akker-van Marle ME, Kaptein AA, Stijnen T, Koopman-van Gemert AWMM, Dahan A, Vliet Vlieland TPMM, Nelissen RGHH, van Bodegom-Vos L.

Implement Sci. 2017 May 30;12(1):72. doi: 10.1186/s13012-017-0601-0.

12.

Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre-based cardiac rehabilitation: Results of the FIT@Home study.

Kraal JJ, Van den Akker-Van Marle ME, Abu-Hanna A, Stut W, Peek N, Kemps HM.

Eur J Prev Cardiol. 2017 Aug;24(12):1260-1273. doi: 10.1177/2047487317710803. Epub 2017 May 23.

13.

Percutaneous laser disc decompression versus conventional microdiscectomy for patients with sciatica: Two-year results of a randomised controlled trial.

Brouwer PA, Brand R, van den Akker-van Marle ME, Jacobs WC, Schenk B, van den Berg-Huijsmans AA, Koes BW, Arts MA, van Buchem MA, Peul WC.

Interv Neuroradiol. 2017 Jun;23(3):313-324. doi: 10.1177/1591019917699981. Epub 2017 Apr 28.

14.

Women's attitude towards routine human platelet antigen-screening in pregnancy.

Winkelhorst D, Loeff RM, van den Akker-Van Marle ME, de Haas M, Oepkes D.

Acta Obstet Gynecol Scand. 2017 Aug;96(8):991-997. doi: 10.1111/aogs.13150. Epub 2017 May 16.

PMID:
28401538
15.

Identifying and prioritizing lower value services from Dutch specialist guidelines and a comparison with the UK do-not-do list.

Wammes JJ, van den Akker-van Marle ME, Verkerk EW, van Dulmen SA, Westert GP, van Asselt AD, Kool RB.

BMC Med. 2016 Nov 25;14(1):196.

16.

Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty.

Voorn VM, van der Hout A, So-Osman C, Vliet Vlieland TP, Nelissen RG, van den Akker-van Marle ME, Dahan A, Marang-van de Mheen PJ, van Bodegom-Vos L.

Vox Sang. 2016 Oct;111(3):219-225. doi: 10.1111/vox.12412. Epub 2016 Jun 17. Review.

PMID:
27314459
17.

Cost-utility of an internet-based intervention with or without therapist support in comparison with a waiting list for individuals with eating disorder symptoms: a randomized controlled trial.

Aardoom JJ, Dingemans AE, van Ginkel JR, Spinhoven P, Van Furth EF, Van den Akker-van Marle ME.

Int J Eat Disord. 2016 Dec;49(12):1068-1076. doi: 10.1002/eat.22587. Epub 2016 Jul 21.

PMID:
27441418
18.

Experiences of women who planned birth in a birth centre compared to alternative planned places of birth. Results of the Dutch Birth Centre Study.

Hitzert M, Hermus MA, Scheerhagen M, Boesveld IC, Wiegers TA, van den Akker-van Marle ME, van Dommelen P, van der Pal-de Bruin KM, de Graaf JP.

Midwifery. 2016 Sep;40:70-8. doi: 10.1016/j.midw.2016.06.004. Epub 2016 Jun 11.

PMID:
27428101
19.

Comprehensively Measuring Health-Related Subjective Well-Being: Dimensionality Analysis for Improved Outcome Assessment in Health Economics.

de Vries M, Emons WH, Plantinga A, Pietersma S, van den Hout WB, Stiggelbout AM, van den Akker-van Marle ME.

Value Health. 2016 Mar-Apr;19(2):167-75. doi: 10.1016/j.jval.2015.11.010. Epub 2016 Jan 28.

20.

Clinical effectiveness, quality of life and cost-effectiveness of Flaminal® versus Flamazine® in the treatment of partial thickness burns: study protocol for a randomized controlled trial.

Rashaan ZM, Krijnen P, van den Akker-van Marle ME, van Baar ME, Vloemans AF, Dokter J, Tempelman FR, van der Vlies CH, Breederveld RS.

Trials. 2016 Mar 5;17(1):122. doi: 10.1186/s13063-016-1240-5.

21.

Economic Evaluation of Concise Cognitive Behavioural Therapy and/or Pharmacotherapy for Depressive and Anxiety Disorders.

Meuldijk D, Carlier IV, van Vliet IM, van Hemert AM, Zitman FG, van den Akker-van Marle ME.

J Ment Health Policy Econ. 2015 Dec;18(4):175-83.

PMID:
26729009
22.

Effectiveness and Clinical Outcomes of a Two-Step Implementation of Conservative Oxygenation Targets in Critically Ill Patients: A Before and After Trial.

Helmerhorst HJ, Schultz MJ, van der Voort PH, Bosman RJ, Juffermans NP, de Wilde RB, van den Akker-van Marle ME, van Bodegom-Vos L, de Vries M, Eslami S, de Keizer NF, Abu-Hanna A, van Westerloo DJ, de Jonge E.

Crit Care Med. 2016 Mar;44(3):554-63. doi: 10.1097/CCM.0000000000001461.

PMID:
26562347
23.

Calculating Preference Weights for the Labor and Delivery Index: A Discrete Choice Experiment on Women's Birth Experiences.

Gärtner FR, de Bekker-Grob EW, Stiggelbout AM, Rijnders ME, Freeman LM, Middeldorp JM, Bloemenkamp KW, de Miranda E, van den Akker-van Marle ME.

Value Health. 2015 Sep;18(6):856-64. doi: 10.1016/j.jval.2015.07.005. Epub 2015 Aug 24.

24.

The Dutch Birth Centre Study: study design of a programmatic evaluation of the effect of birth centre care in the Netherlands.

Hermus MA, Wiegers TA, Hitzert MF, Boesveld IC, van den Akker-van Marle ME, Akkermans HA, Bruijnzeels MA, Franx A, de Graaf JP, Rijnders ME, Steegers EA, van der Pal-de Bruin KM.

BMC Pregnancy Childbirth. 2015 Jul 16;15:148. doi: 10.1186/s12884-015-0585-1.

25.

Cost and effects of risk factor guided screening strategies for retinopathy of prematurity for different treatment strategies.

van den Akker-van Marle ME, van Sorge AJ, Schalij-Delfos NE.

Acta Ophthalmol. 2015 Dec;93(8):706-12. doi: 10.1111/aos.12798. Epub 2015 Jul 6.

26.

Good reliability and validity for a new utility instrument measuring the birth experience, the Labor and Delivery Index.

Gärtner FR, de Miranda E, Rijnders ME, Freeman LM, Middeldorp JM, Bloemenkamp KW, Stiggelbout AM, van den Akker-van Marle ME.

J Clin Epidemiol. 2015 Oct;68(10):1184-94. doi: 10.1016/j.jclinepi.2015.05.020. Epub 2015 May 27.

PMID:
26115813
27.

The relative importance of the domains of work functioning: evaluations of health-impaired employees, healthy employees, and employers.

Boezeman EJ, Nieuwenhuijsen K, de Bekker-Grob EW, van den Akker-van Marle ME, Sluiter JK.

J Occup Environ Med. 2015 Apr;57(4):361-6. doi: 10.1097/JOM.0000000000000361.

PMID:
25851183
28.

Patient controlled analgesia with remifentanil versus epidural analgesia in labour: randomised multicentre equivalence trial.

Freeman LM, Bloemenkamp KW, Franssen MT, Papatsonis DN, Hajenius PJ, Hollmann MW, Woiski MD, Porath M, van den Berg HJ, van Beek E, Borchert OW, Schuitemaker N, Sikkema JM, Kuipers AH, Logtenberg SL, van der Salm PC, Oude Rengerink K, Lopriore E, van den Akker-van Marle ME, le Cessie S, van Lith JM, Struys MM, Mol BW, Dahan A, Middeldorp JM.

BMJ. 2015 Feb 23;350:h846. doi: 10.1136/bmj.h846.

29.

Percutaneous laser disc decompression versus conventional microdiscectomy in sciatica: a randomized controlled trial.

Brouwer PA, Brand R, van den Akker-van Marle ME, Jacobs WC, Schenk B, van den Berg-Huijsmans AA, Koes BW, van Buchem MA, Arts MP, Peul WC.

Spine J. 2015 May 1;15(5):857-65. doi: 10.1016/j.spinee.2015.01.020. Epub 2015 Jan 20.

PMID:
25614151
30.

IPD without bony decompression versus conventional surgical decompression for lumbar spinal stenosis: 2-year results of a double-blind randomized controlled trial.

Moojen WA, Arts MP, Jacobs WC, van Zwet EW, van den Akker-van Marle ME, Koes BW, Vleggeert-Lankamp CL, Peul WC; Leiden The Hague Spine Intervention Prognostic Study Group (SIPS).

Eur Spine J. 2015 Oct;24(10):2295-305. doi: 10.1007/s00586-014-3748-2. Epub 2015 Jan 14.

PMID:
25586759
31.

Interspinous process device versus standard conventional surgical decompression for lumbar spinal stenosis: randomised controlled trial.

Moojen WA, Arts MP, Jacobs WC, van Zwet EW, van den Akker-van Marle ME, Koes BW, Vleggeert-Lankamp CL, Peul WC; Leiden-The Hague Spine Intervention Prognostic Study Group (SIPS).

Br J Sports Med. 2015 Jan;49(2):135. doi: 10.1136/bjsports-2014-f6415rep.

PMID:
25552601
32.

Interspinous process devices versus standard conventional surgical decompression for lumbar spinal stenosis: cost-utility analysis.

van den Akker-van Marle ME, Moojen WA, Arts MP, Vleggeert-Lankamp CL, Peul WC; Leiden-The Hague Spine Intervention Prognostic Study Group (SIPS).

Spine J. 2016 Jun;16(6):702-10. doi: 10.1016/j.spinee.2014.10.017. Epub 2014 Oct 23.

PMID:
25452018
33.

Effects of home-based training with telemonitoring guidance in low to moderate risk patients entering cardiac rehabilitation: short-term results of the FIT@Home study.

Kraal JJ, Peek N, Van den Akker-Van Marle ME, Kemps HM.

Eur J Prev Cardiol. 2014 Nov;21(2 Suppl):26-31. doi: 10.1177/2047487314552606.

PMID:
25354951
34.

Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data.

van der Ploeg CP, van den Akker-van Marle ME, Vernooij-van Langen AM, Elvers LH, Gille JJ, Verkerk PH, Dankert-Roelse JE; CHOPIN study group.

J Cyst Fibros. 2015 Mar;14(2):194-202. doi: 10.1016/j.jcf.2014.08.007. Epub 2014 Sep 10.

35.

Choosing your health insurance package: a method for measuring the public's preferences for changes in the national health insurance plan.

Victoor A, Hansen J, van den Akker-van Marle ME, van den Berg B, van den Hout WB, de Jong JD.

Health Policy. 2014 Aug;117(2):257-65. doi: 10.1016/j.healthpol.2014.04.017. Epub 2014 May 5.

PMID:
24875333
36.

A comprehensive representation of the birth-experience: identification and prioritization of birth-specific domains based on a mixed-method design.

Gärtner FR, Freeman LM, Rijnders ME, Middeldorp JM, Bloemenkamp KW, Stiggelbout AM, van den Akker-van Marle ME.

BMC Pregnancy Childbirth. 2014 Apr 24;14:147. doi: 10.1186/1471-2393-14-147. Review.

37.

De-implementation of expensive blood saving measures in hip and knee arthroplasties: study protocol for the LISBOA-II cluster randomized trial.

Voorn VM, Marang-van de Mheen PJ, So-Osman C, Kaptein AA, van der Hout A, van den Akker-van Marle ME, Koopman-van Gemert AW, Dahan A, Nelissen RG, Vliet Vlieland TP, van Bodegom-Vos L.

Implement Sci. 2014 Apr 23;9:48. doi: 10.1186/1748-5908-9-48.

38.

Domains of quality of life: results of a three-stage Delphi consensus procedure among patients, family of patients, clinicians, scientists and the general public.

Pietersma S, de Vries M, van den Akker-van Marle ME.

Qual Life Res. 2014 Jun;23(5):1543-56. doi: 10.1007/s11136-013-0578-3. Epub 2013 Nov 17.

39.

Interspinous process device versus standard conventional surgical decompression for lumbar spinal stenosis: randomized controlled trial.

Moojen WA, Arts MP, Jacobs WC, van Zwet EW, van den Akker-van Marle ME, Koes BW, Vleggeert-Lankamp CL, Peul WC; Leiden-The Hague Spine Intervention Prognostic Study Group.

BMJ. 2013 Nov 14;347:f6415. doi: 10.1136/bmj.f6415.

40.

Effects and costs of home-based training with telemonitoring guidance in low to moderate risk patients entering cardiac rehabilitation: The FIT@Home study.

Kraal JJ, Peek N, van den Akker-Van Marle ME, Kemps HM.

BMC Cardiovasc Disord. 2013 Oct 8;13:82. doi: 10.1186/1471-2261-13-82.

41.

Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia.

van den Hurk CJ, van den Akker-van Marle ME, Breed WP, van de Poll-Franse LV, Nortier JW, Coebergh JW.

Acta Oncol. 2014 Jan;53(1):80-7. doi: 10.3109/0284186X.2013.794955. Epub 2013 Sep 23.

PMID:
24059270
42.

Cost-effectiveness of primary prevention implantable cardioverter defibrillator treatment: data from a large clinical registry.

Thijssen J, van den Akker van Marle ME, Borleffs CJ, van Rees JB, de Bie MK, van der Velde ET, van Erven L, Schalij MJ.

Pacing Clin Electrophysiol. 2014 Jan;37(1):25-34. doi: 10.1111/pace.12238. Epub 2013 Sep 2.

PMID:
23998638
43.

Implementation of a cost-effective strategy to prevent neonatal early-onset group B haemolytic streptococcus disease in the Netherlands.

Kolkman DG, Rijnders ME, Wouters MG, van den Akker-van Marle ME, van der Ploeg CK, de Groot CJ, Fleuren MA.

BMC Pregnancy Childbirth. 2013 Jul 30;13:155. doi: 10.1186/1471-2393-13-155.

44.

Management of undescended testis: a decision analysis.

van den Akker-van Marle ME, Kamphuis M, van Gameren-Oosterom HB, Pierik FH, Kievit J; NST Expert Group.

Med Decis Making. 2013 Oct;33(7):906-19. doi: 10.1177/0272989X13493145. Epub 2013 Jul 2.

PMID:
23819984
45.

Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.

van den Hurk CJ, van den Akker-van Marle ME, Breed WP, van de Poll-Franse LV, Nortier JW, Coebergh JW.

Eur J Oncol Nurs. 2013 Oct;17(5):536-40. doi: 10.1016/j.ejon.2013.02.004. Epub 2013 Apr 6.

PMID:
23571182
46.

Cost of rheumatic disorders in the Netherlands.

van den Akker-van Marle ME, Chorus AM, Vliet Vlieland TP, van den Hout WB.

Best Pract Res Clin Rheumatol. 2012 Oct;26(5):721-31. doi: 10.1016/j.berh.2012.08.005. Review.

PMID:
23218434
47.

Remifentanil patient controlled analgesia versus epidural analgesia in labour. A multicentre randomized controlled trial.

Freeman LM, Bloemenkamp KW, Franssen MT, Papatsonis DN, Hajenius PJ, van Huizen ME, Bremer HA, van den Akker ES, Woiski MD, Porath MM, van Beek E, Schuitemaker N, van der Salm PC, Fong BF, Radder C, Bax CJ, Sikkema M, van den Akker-van Marle ME, van Lith JM, Lopriore E, Uildriks RJ, Struys MM, Mol BW, Dahan A, Middeldorp JM.

BMC Pregnancy Childbirth. 2012 Jul 2;12:63. doi: 10.1186/1471-2393-12-63.

48.

Urethral catheters: can we reduce use?

van den Broek PJ, Wille JC, van Benthem BH, Perenboom RJ, van den Akker-van Marle ME, Niël-Weise BS.

BMC Urol. 2011 May 23;11:10. doi: 10.1186/1471-2490-11-10.

49.

Cost-effectiveness of 4 neonatal screening strategies for cystic fibrosis.

van den Akker-van Marle ME, Dankert HM, Verkerk PH, Dankert-Roelse JE.

Pediatrics. 2006 Sep;118(3):896-905.

PMID:
16950979
50.

Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe.

van den Akker-van Marle ME, Gurwitz D, Detmar SB, Enzing CM, Hopkins MM, Gutierrez de Mesa E, Ibarreta D.

Pharmacogenomics. 2006 Jul;7(5):783-92.

PMID:
16886902

Supplemental Content

Loading ...
Support Center